Modifying Antiretroviral Therapy in Virologically Suppressed HIV-Infected Patients
Summary
- Potential reasons for considering a modification to the antiretroviral regimen of a virologically suppressed patient include tolerability and toxicity (Table 1)[Elzi 2010] and/or to preserve treatment options, avoid or manage drug–drug or drug–food interactions, or decrease cost (Table 2)
- The DHHS antiretroviral therapy guidelines panel outlines specific criteria for patients on suppressive antiretroviral therapy to be considered for treatment modification (Management Guidelines)[DHHS ART]
- The panel recently instituted evidence-based categorization of switch strategies for virologically suppressed patients into strategies with good supporting evidence, strategies with some evidence, or strategies not recommended (Table 3)
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Switch Strategies